Replies to post #9542 on Seelos Therapeutics Inc (SEEL)

[kingme123]

Shazam619 posted the info first I believe. Will be done in 4 to 8 weeks.Final data Dec 2015. U.S. FDA Resources



Further study details as provided by Lawson Health Research Institute:



Primary Outcome Measures: •The efficacy of Topical alprostadil in the treatment of erectile dysfunction as measured by IIEF scores. [ Time Frame: 4 - 8weeks ] [ Designated as safety issue: Yes ]



Secondary Outcome Measures: •Evaluate patient satisfaction of transdermal topical alprostadil when compared to patient's most current mode of therapy for erectile dysfunction. [ Time Frame: 4 - 8 weeks ] [ Designated as safety issue: No ]



Estimated Enrollment: 100
Study Start Date: December 2013
Estimated Study Completion Date: December 2015
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)